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Abstract	
Objective:		To	characterise	the	microbiome	in	healthy	women	with	no	bladder	symptoms	and	to	
compare	this	to	the	bladder	microbiome	in	patients	with		overactive	bladder	syndrome	(OAB).				
Study	Design:	MSU	specimens	from	63	women	with	OAB	were	compared	to	urine	from	35	controls.		
Urine	was	centrifuged	and	the	resulting	sediment	pellet	was	re-suspended	in	supernatant	and	plated	
under	 aerobic	 conditions	 for	 48	 hours	 and	 anaerobic	 conditions	 for	 7	 days.	 Each	morphologically	
distinct	 colony	 was	 purity	 plated.	 Bacterial	 colonies	 were	 lysed	 and	 polymerase	 chain	 reaction	
undertaken	to	amplify	the	16s	ribosomal	RNA	gene.	This	DNA	was	purified	and	sequenced	allowing	
identification	of	bacterial	genera.	
Results:		The	mean	number	of	different	bacterial	genera	was	5.0	in	both	controls	and	OAB	patients	(p	
=	0.99).	The	uropathogenic		bacteria		Proteus	(P=0.01)	was	more	commonly	isolated	from	women	with	
OAB.	 	 The	 genus	 lactobacillus	 was	 present	 more	 commonly	 in	 urine	 taken	 from	 controls	 	 when	
compared	 to	 urine	 from	OAB	patients	 (p=0.02).	Overall	 the	most	 commonly	 grown	bacteria	were	
staphylococcus	 (grown	 in	 59%	 of	 samples),	 streptococccus	 (51%),	 corynebacterium	 (37%)	 and	
lactobacillus	(28%).	A	total	of	95	different	genera	were	identified	from	the	urine	samples.	
Conclusion:	 The	 female	 human	 bladder	 has	 a	 diverse	 microbiome	 with	 stastistically	 significant	
differences	between	bacterial	species	present	in	OAB	patients	and	controls.		
	
Keywords:	
Microbiome,	Overactive	Bladder,	Women,	urinary	incontinence		
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Introduction	
Historically	urine	was	considered	to	be	sterile	but	current	evidence	suggests	that	this	is	not	the	case	
[1].	 	 The	 recent	 development	 and	 application	 of	 16s	 ribosomal	 RNA	 (rRNA)	 gene	 sequencing	
technology		has	revealed	that	like	the	skin	or	gut,	the	‘healthy’	bladder	contains	bacteria	which	are	
not	always	associated	with	a	disease	process	[2].	Multiple	organisms	can	be	identified	in	the	urine	of	
women	with	and	without	overactive	bladder	(OAB)	with	a	negative	mid-	stream	urine	(MSU)	culture	
processed	 in	a	hospital	microbiology	 laboratory	 [1,3].	The	way	 in	which	 these	organisms	exist	and	
interact	with	 their	 environment	 is	 called	 the	microbiome	 [4].	 Several	 studies	 have	 now	 identified	
differences	in	the	bacterial	load	[5]	and	species	present	[6]	in	urine	taken	from	women	with	overactive	
bladder	(OAB)	compared	to	healthy	controls.	The	presence	of	 low	 levels	of	bacteria	 in	the	bladder	
could	be	considered	as	an	interesting	idiosyncrasy	without	any	consequences	but	importantly	these	
differences	are	associated	with	clinical	symptoms	and	outcomes	[7-8].		OAB	is	a	syndromal	diagnosis	
with	multiple	different	pathologies	causing	similar	symptoms.	Variations	in	the	microbiome	may	be	
important	 in	 patients	with	OAB.	 In	 some	 patients	 the	microbiome	may	 have	 a	 pivotal	 role	 in	 the	
aetiology	 of	 OAB	 symptoms	 and	 additional	 identification	 and	 characterisation	 may	 allow	 us	 to	
maximise	our	therapeutic	interventions.	Known	pathogens	have	been	identified	more	commonly	in	
patients	with	OAB	compared	to	controls	[9].	Conversely,not	all	organisms	are	found	more	commonly	
in	patients	with	OAB	compared	to	controls.	Several	studies	have	suggested	an	increased	prevalence	
of	certain	bacteria,	such	as	lactobacillus,	in	controls	compared	to	patients	with	OAB	[9-11].	Similarly,	
some	studies	have	found	a	reduced	prevalence	of	Lactobacillus	 in	patients	with	bladder	symptoms	
[1,6,12].			
The	 study	 aimed	 to	 identify	 which	 organisms	 might	 be	 the	 focus	 for	 further	 research	 as	
therapeutic	targets;	either	to	promote	organisms	associated	with	positive	microbiological	health	or	
targeting	 those	 organisms	 associated	with	OAB	 symptoms.	 	 The	 hypothesis	was	 that	 lactobacillus	
would	be	found	more	commonly	in	control	patients	compared	to	OAB	patients	and	that	other	known	
uropathogens	would	be	found	more	commonly	in	OAB.		
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Materials	and	Methods	
Patients	and	Sample	Collection:	
A	consecutive	cohort	of	60	women	attending	a	urogynaecology	clinic	with	symptoms	of		OAB	were		
identified	and	consented	to	participate	in	the	study.	All	control	female	subjects	(n=35)	were	recruited	
from	patients	attending	a	general	gynaecology	clinic	and	members	of	staff.		Demographic	data	were	
recorded	 for	 all	 patients	 and	 a	 pelvic	 examination	was	 undertaken.	 	 Symptoms	were	 assessed	 by	
careful	 clinical	 questioning	 for	 symptoms	 of	 OAB	 and	 by	 completion	 of	 a	 validated	 symptom	
questionnaire	(ICIQ-	FLUTS).	Control	patients	were	excluded	if	they	reported	any	bladder	symptoms	
on	the	 ICIQ	Short	Form.	 	Any	patients	with	prolapse	 (>Stage	1	POP-Q)	or	urodynamic	 	evidence	of	
stress	 incontinence	were	 excluded	 from	 the	 study.	 Severity	 of	 symptoms	was	 assessed	 using	 the	
patient	global	impression	of	severity	scale	(PGI-S).	Leaks	per	week	were	assessed	subjectively	on	the	
scale	 0-6,	 7-14,	 >14.	 Urodynamic	 studies	 were	 not	 required	 for	 inclusion	 but	 most	 patients	 had	
undergone	 this	 test.	 The	use	of	 vaginal,	 transdermal	 or	 oral	 hormone	 replacement	 therapy	was	 a	
contraindication	for	this	study.	
A	clean	catch	mid-stream	urine	(MSU)	was	taken	from	all	participants.	A	sample	was	sent	for	
routine	hospital	clinical	microbiological	assessment	and	patients	with	a	positive	MSU	(>	1x	10
5
	cfu)	for	
UTI	were	excluded.	The	urine	remaining	from	the	original	sample	collection	was	subsequently	taken	
for	further	study	specific	laboratory	testing	within	four	hours	of	initial	collection.		
Bacterial	species	isolation	and	amplification:		
A	5	ml	urine	sample	was	 taken	and	centrifuged	at	800rpm	for	5	mins,	 the	 resulting	pellet	was	 re-
suspended	in	50 μl of	the	supernatant	and	5	μl	streaked	onto	two	chocolate	agar	plates	(E	and	O	
laboratories).	 Both	 plates	 were	 incubated	 at	 37
o
C,	 one	 in	 5%	 CO2	 for	 48	 hours,	 the	 other	 in	 an	
anaerobic	glove	box	isolator	for	7	days	to	ensure	anaerobic	conditions.	Each	morphologically	distinct	
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colony	was	then	purity	plated	and	incubated	in	the	same	conditions	for	a	further	48	hours.	Aseptic	
techniques	were	employed	throughout.	
Bacteria	colonies	were	picked	from	purity	plates	and	5	μl	 inoculations	of	each	isolate	were	
suspended	in	100	μl	sterile	nuclease	free	water	(Thermo	Scientific)	in	a	PCR	reaction	tube.	Bacterial	
lysis	 was	 performed	 using	 an	 Eppendorf	Mastercycler	 set	 to	 94
O
C	 for	 5	 minutes	 to	 extract	 DNA.	
Polymerase	chain	reaction	(PCR)	was	then	performed	to	amplify	a	variable	region	(V9)	of	the	bacterial	
16S	rRNA	gene	5	μl	of	the	lysed	bacteria	was	combined	with	12.5	μl	Q5	Polymerase	Mastermix	(NEB),	
1.25	μL	forward	primer	(DG74Fwd	-	5’-AGG	AGC	TGA	TCC	AAC	CGC	A-3’	-	Eurofins),	1.25	μl	reverse	
primer	(RDR080Rev	-	5’-AAC	TGG	AGG	AAG	GTG	GGG	AC-3’-Eurofins)	and	5	μl	sterile	nuclease	free	
water.	The	reaction	was	run	on	an	Eppendorf	Mastercycler	at	the	following	temperatures	and	times:	
-	1)	98
O
C	for	30	seconds	(denature),	2)	98
O
C	for	10	seconds	(denature),	3)	55
O
C	for	20	seconds	(anneal),	
4)	72
O
C	for	20	seconds	(extend)	[Steps	2-4	repeated	37	times]	5)	72
O
C	for	2	minutes	(final	extension).	
All	 PCR	 amplicons	 were	 checked	 for	 reaction	 success	 and	 purity	 by	 loading	 on	 a	 1%	 agarose	 gel	
containing	 ethidium	 bromide	 (Fisher)	 and	 run	 at	 120	 V	 for	 90	 minutes.	 PCR	 reactions	 were	 run	
alongside	nuclease	free	water	as	a	negative	control.	
The	resultant	DNA	was	purified	using	a	PCR	Purification	Kit	(Qiagen)	and	the	concentration	of	
each	product	was	recorded	using	a	Nanodrop	2000	(Thermo	Scientific).	For	each	sample,	15	μl	of	the	
PCR	product,	adjusted	to	5	ng/μl	using	purified	nuclease	free	water,	was	added	to	2.5	μl	primer	in	a	
mix2Seq	 tube	 (Eurofins)	 and	 sent	 to	 Eurofins	 Genomics,	 Ebersburg,	 Germany	 for	 sequencing.	 A	
microbe	genomic	BLAST	(Basic	Local	Alignment	Search	Tool,	PubMed)	was	performed	on	the	returned	
sequences	and	the	identity	of	the	 individual	microbes	recorded.	The	results	of	the	sequencing	was	
correlated	with	the	results	of	gram	staining.	Sequences	that	could	not	be	classified	to	the	bacterial	
genus	level	were	excluded	from	further	analysis.	
Using	the	16s	rRNA	gene	sequence	information	a	microbiome	profile	was	developed	for	each	
woman.	The	percentage	frequencies	of	genera	were	then	compared	between	control	and	women	with	
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OAB	and	analysed	by	Fisher	Exact	test.	A	minimum	sample	size	of	more	than	25	in	each	arm	was	used	
as	 per	 recommendations	 by	 Machin	 when	 means	 and	 standard	 deviations	 are	 uncertain	 [13].		
Demographic	 data	 was	 compared	 between	 controls	 and	 women	 with	 OAB	 using	 the	 unpaired	
Student’s	t	test.	All	terminology	and	urodynamic	definitions	conform	to	IUGA/ICS	standardization	[14].	
The	 study	 was	 performed	 in	 accordance	 with	 the	 Declaration	 of	 Helsinki.	 The	 collection	 of	 urine	
samples	in	the	study	were	approved	by	the	National	Research	Ethics	Service	where	required.			
Results	
The	urine	samples	of	95	women	were	analysed	(60	from	women	with	OAB	and	35	from	healthy	female	
controls	with	over	700	bacterial	colonies	characterised.	Three	patients	had	a	confirmed	UTI	on	hospital	
culture	and	were	excluded	from	further	analysis.		The	demographics	of	controls	and	women	with	OAB	
were	similar	although	more	control	patients	had	undergone	previous	urogynaecological	surgery	(see	
table	1).	The	significance	of	this	is	uncertain.	No	patient	had	a	history	of	recurrent	UTIs.	88%	of	OAB	
patients	were	either	currently	on	or	had	previously	been	on	anticholinergic	medication	consistent	with	
the	referral	pattern	to	a	specialist	urogynaecological	clinic.	The	majority	of	our	OAB	women	scored	
their	OAB	symptoms	as	either	moderate	or	severe	and	 included	some	women	who	had	previously	
tried	4	or	more	anticholinergic	medications.	Most	of	the	patients	were	OAB	wet	with	leaks	daily	or	
more	 often	 in	 68%	 of	 women	 (see	 table	 2).	 No	 subjects	 were	 using	 oral	 or	 vaginal	 lactobacillus	
preparations	
The	mean	number	of	different	bacterial	genera	was	5	in	urine	samples	of	both	the	control	and	
OAB	group	(5.0	control	v	5.0	OAB).	Of	all	urine	samples	 tested,	97.8	%	grew	at	 least	one	bacterial	
species	and	a	total	of	66	different	bacterial	genera	were	identified	resident	in	the	urine	of	both	cohorts	
at	 different	 frequencies	 (appendix	 1).	 The	 most	 frequently	 grown	 organisms	 from	 all	 samples	
expressed	 as	 percentage	 frequency,	 were	 staphylococcus	 (59%),	 streptococccus	 (51%),	
corynebacterium	(37%)	and	 lactobacillus	(28%).	Figure	1	shows	the	frequency	in	which	the	25	most	
commonly	grown	bacterial	genera	were	found	in	healthy	female	controls	and	women	with	OAB.		
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There	were	significant	differences	found	in	the	prevalence	of	certain	organisms	in	the	bladder	
of	women	with	OAB	and	healthy	controls	 (Fisher’s	exact	test).	Lactobacillus	was	more	prevalent	 in	
bladders	of	controls	(43%	controls	v	20%	OAB	p=	0.02)	whilst	Proteus	featured	more	often	in	women	
with	OAB	 (3%	 controls	 v	 23%	OAB	 p=0.01).	 16%	of	 bacterial	 sequences	 could	 not	 be	 classified	 to	
bacterial	genus	level.		
	
Comment	
This	study	supports	the	previous	findings	of	the	existance	of	a	bladder	microbiome	and	also	shows	
significant	 differences	 between	 the	 prevalence	 of	 different	 bacterial	 genera	 in	 healthy	 controls	
compared	to	patients	with	OAB.	Lactobacillus	is	found	more	commonly	in	control	patients	compared	
to	patients	with	OAB.	This	is	the	first	study	assigning	statistical	significance	to	this	finding.	The	urinary	
pathogen	Proteus	was	found	statistically	more	commonly	in	patients	with	OAB.		
There	have	been	several	previous	studies	focused	on	characterising	the	bladder	microbiome	
in	healthy	individuals	and	in	patients	with	bladder	symptoms	[1,6,12].	In	common	with	other	studies	
[1,6,9-12],	the	most	noticeable	result	from	the	current	study	is	the	significantly	greater	prevalence	of	
Lactobacillus	in	controls	compared	to	patients	with	bladder	symptoms.	Hilt	et	al	found	Lactobacillus	
in	29%	of	control	urine	samples	compared	with	12%	of	urine	samples	 from	patients	with	OAB	[1].	
Moreover,	 another	 study	 comparing	 bacteria	 in	 the	 urine	 from	 women	 with	 urgency	 urinary	
incontinence	 (UUI)	 to	 that	 in	 the	urine	of	controls	 found	decreased	Lactobacillus	amongst	 the	UUI	
group	 [6].	 The	 urine	 samples	 in	 both	 of	 these	 studies	were	 collected	by	 transurethral	 catheter	 as	
opposed	to	MSU	suggesting	that	 lactobacillus	 is	 likely	to	be	present	 in	the	female	bladder	and	not	
present	simply	from	contamination	from	the	genital	tract	during	MSU	collection	[1,6].	Lactobacillus	
has	additionally	been	identified	in	the	urine	of	men	[12,15]	and	from	suprapubic	aspirate	[2]	providing	
further	evidence	that	Lactobacillus	colonisation	of	urine	 is	not	solely	due	to	vaginal	contamination.	
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Lactobacilli	are	able	to	produce	bacteriocins	which	have	antibacterial	activity	[16]	which	could	possibly	
help	explain	its	protective	role.	Diversity	has	been	identified	as	a	factor	by	other	authors	but	this	did	
not	seem	to	be	a	factor	in	this	study	as	both	controls	and	OAB	patients	grew	the	same	mean	number	
of	genera	(5	genera).			
In	 this	 study,	 unlike	 preceding	 studies,	 large	 numbers	 of	 patient	 urine	 samples	 allowed	
statistical	significance	to	be	determined	for	differences	in	the	prevalence	of	some	bacterial	genera.	
The	data	statistically	confirmed	some	trends	previously	noted	in	other	studies	and	whilst	no	formal	
allowance	for	multiple	analyses	has	been	made,	the	fact	that	our	findings	mirror	other	smaller	studies	
and	are	biologically	plausible	means,	the	results	are	likely	to	be	reliable.	The	methodological	approach	
to	this	study	is	culture	dependant,	which	has	advantages	and	disadvantages.	There	is	the	possibility	of	
not	identifying	bacteria	which	do	not	grow	in	the	culture	conditions	used	in	this	study.	However,	all	
bacteria	identified	can	be	assumed	to	be	viable.	Other	authors	have	identified	bacteria	using	culture	
independent	methods	 amplifiying	 16S	 rRNA	 gene	 sequences	 directly	 from	urine.	Work	 comparing	
extended	culture	and	culture	independent	methods	have	found	there	to	be	similar	genera	identified	
using	 both	 approaches	 [1,6]	 .	 Culture	 independent	 methods	 tends	 to	 identify	 large	 numbers	 of	
bacteria	species	but	not	all	samples	contain	DNA	in	sufficient	quantities	[17]	and	cannot	confirm	the	
sequences	 are	 from	 bacteria	 that	 can	 survive,	 reproduce	 and	 be	 metabolically	 active	 within	 the	
bladder	[2,3].	The	number	of	urine	samples	from	which	bacteria	were	successfully	cultured	was	higher	
in	our	study	than	Hilt	et	al	in	the	extended	culture	arm	of	their	study	who	identified	bacteria	in	just	
80%	of	samples	[1].	Neither	technique	allows	true	quantification	as	primers	will	amplify	genera	with	
different	 degrees	 of	 efficiency.	 The	 study	 of	 microbiomes	 is	 therefore	 largely	 descriptive	 and	
comparative.		
This	study	is	based	on	clean	catch	MSU	samples	but	there	is	debate	as	to	whether	MSUs	or	
CSUs	are	the	best	way	to	sample	the	bladder	microbiome.		A	review	of	this	subject	failed	to	reach	a	
conclusion	as	to	which	technique	is	preferable	[18].	Some	research	centres	favour	CSUs	whilst	others	
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use	MSU	samples	citing	the	fact	that	similar	organisms	are	isolated	from	MSU	and	CSU	samples	[9].	
This	 is	supported	by	the	current	study	where	4	of	the	5	most	prevalent	bacteria	were	the	same	as	
those	demonstrated	by	Hilt	using	a	CSU	technique	[1].	Other	research	sites	have	argued	in	favour	of	
CSUs	but	have	recognised	the	necessity	to	use	MSUs	in	ongoing	research	[7].	In	common	with	other	
centres,	our	current	research	found	serial	CSUs	unacceptable	to	patients	[9].	This	has	been	overcome	
in	some	centres	by	obtaining	urine	specimens	under	general	anaesthesia	[2]	but	this	was	not	an	option	
in	the	current	study.	CSUs	sample	urine	in	the	bladder	and	also	any	organisms	shed	from	higher	in	the	
renal	tract.	 	There	may	be	some	benefit	 in	obtaining	organisms	that	reside	in	the	urethra	as	this	 is	
deemed	to	be	the	origin	of	urgency	 in	some	theories	of	 incontinence.	 	A	study	comparing	CSUs	to	
MSUs	and	relating	this	to	symptoms	is	needed	to	fully	address	this.	
Data	 trends	 observed	 in	 this	 study	 regarding	 pathogenic	 organisms,	 commonly	 seen	 in	
patients	with	urinary	tract	infection,	indicated	that	these	bacteria	were	more	commonly	identified	in	
the	urine	of	patients	with	OAB	than	urine	of	controls.	Proteus	was	statistically	more	commonly	grown	
from	the	urine	of	women	with	OAB.	Khasriya	also	 found	proteus	more	commonly	 in	patients	with	
lower	urinary	tract	symptoms	(LUTS)	compared	to	controls	[9].	There	were	similar	but	non	significant	
trends	for	other	known	urinary	pathogens	such	as	E.	coli..	It	is	likely	that	the	study	is	underpowered	
to	show	all	associations.		The	mechanism	by	which	these	organisms	cause	OAB	is	uncertain	but	may	
be	 due	 to	 altered	 urothelial	 ATP	 signalling	 [19].	 Observational	 non	 randomised	 studies	 using	
antibiotics	 have	 suggested	 a	 benefit	 in	 alleviating	 OAB	 symptoms	 but	 they	 did	 not	 include	 an	
assessment	on	the	effect	on	the	microbiome	[20].	Current	studies	are	in	progress	to	assess	the	effect	
of	antibiotic	therapy	on	the	bladder	microbiome.	 	There	was	no	significant	difference	between	the	
age	of	cases	and	controls	but	OAB	patients	were	5.5	years	older.	Although	not	statistically	different	
this	might	result	in	a	different	microbiome	in	the	vaginal	which	might	affect	the	bladder	microbiome.	
This	 can	only	 be	 tested	by	 therapeutic	 trials	 assessing	 the	 effect	 of	 interventions	 in	 the	 vagina	 to	
identify	if	these	affect	the	bladder	microbiome.	To	date	these	trails	have	not	been	performed.		
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There	are	statistically	significant	differences,	in	the	prevalence	of	some	organisms	between	
controls	and	women	with	OAB.	Collectively	these	results	suggest	that	Lactobacillus	may	be	protective	
against	OAB	but	 cause	 and	 effect	 needs	 further	 study.	 Future	 research	 should	 focus	 on	 antibiotic	
treatment	against	pathogenic	organisms	and	probiotics	to	stimulate	a	positive	bladder	microbiome.		
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Legend	figure	1		
This	graph	depicts	the	25	most	commonly,	grown	bacterial	genera	and	compares	the	frequency	in	
which	they	were	grown	from	the	bladder	microbiome	of	women	with	OAB	(orange)	and	Control	
women	(blue).	P	values	are	shown.		
*=	statistically	significant	
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Table 1
Demographics details of	patient
and	controls
Controls
(n=35)
OAB
(n=60)
P value
Age (range) 53.7 (41-83) 59.2 (14-87) 0.07
Diabetes 9% 7% 1
BMI 27.2 29.4 0.11
Median Parity 2 2 1
Anticholinergics 0% 87.7% <0.01ᵃ
Previous
urogynae
surgery
10/35 32/57 0.02ᵃ
ᵃ	Statistically significant difference. Urogynae=urogynaecological;
prolapse or	incontinence surgery.
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Table	2
Characteristics of patients	with	OAB
Percentage of OAB	
women
Subjective	Severity Mild 12.3 % (7/57)
Moderate 19.3	% (11/57)
Severe 68.4% % (39/57)
Number	of 0 12.3 % (7/57)
Anticholinergics 1 36.8	% (22/57)
Previously	used 2 7.0 % (4/57)
3 14.0	% (8/57)
4 22.8 % (13/57)
>4 5.3 % (34/57)
Leaks per week 0-6 32.1	% (18/57)
7-14 7.1	% (4/57)
>14 59.6	% (34/57)
Previous intravesical
botox
0% (0/57)
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Fig.	1.	This	graph	depicts	the	25	most	commonly,	grown	bacterial	genera	and	
compares	the	frequency	in	which	they	were	grown	from	the	bladder	
microbiome	of	women	with	OAB	(orange)	and	Control	women	(blue).	P	values	
are	shown.	*	=	statistically	signiﬁcant.	(For	interpretation	of	the	references	to	
colour in	this	ﬁgure	legend,	the	reader	is	referred	to	the	web	version	of	this	
article.)
